Studies of epithelial tumours have consistently shown that the downregulation of RARβ2 is a crucial event in malignancy and that the subsequent aberrant expression of E-cadherin/β-catenin complexes correlates with the conversion of early-stage tumours into invasive malignancies [15], [16]. The gene discussed is CDH1; the disease is neoplasm.